Imidazole macrocycles for the treatment of autoimmune disease

The present invention relates to compounds of formula (Ia), wherein R2, M1, M2, M3, Q1 and Q2 are as described herein, and their pharmaceutically acceptable salt thereof, and compositions including the compounds and methods of using the compounds.

Saved in:
Bibliographic Details
Main Authors GUBA, WOLFGANG, LIN, ZHAO-HU, WU, YAO, ZHU, WEI, ZHANG, WEI-XING, ZHANG, ZHI-WEI, LIU, YA-FEI, ZHANG, ZHEN-HONG, JIANG, MIN, LIU, HAI-XIA, HAN, XINGUN, ZHU, JIAN-SHENG, KOU, BU-YU, CHEN, JIAN-GUO, CHEN, SHUAI, SHEN, HONG
Format Patent
LanguageChinese
English
Published 01.11.2023
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

Abstract The present invention relates to compounds of formula (Ia), wherein R2, M1, M2, M3, Q1 and Q2 are as described herein, and their pharmaceutically acceptable salt thereof, and compositions including the compounds and methods of using the compounds.
AbstractList The present invention relates to compounds of formula (Ia), wherein R2, M1, M2, M3, Q1 and Q2 are as described herein, and their pharmaceutically acceptable salt thereof, and compositions including the compounds and methods of using the compounds.
Author LIU, HAI-XIA
LIU, YA-FEI
ZHANG, ZHI-WEI
GUBA, WOLFGANG
HAN, XINGUN
KOU, BU-YU
CHEN, JIAN-GUO
WU, YAO
ZHANG, WEI-XING
ZHU, JIAN-SHENG
SHEN, HONG
ZHU, WEI
ZHANG, ZHEN-HONG
CHEN, SHUAI
JIANG, MIN
LIN, ZHAO-HU
Author_xml – fullname: GUBA, WOLFGANG
– fullname: LIN, ZHAO-HU
– fullname: WU, YAO
– fullname: ZHU, WEI
– fullname: ZHANG, WEI-XING
– fullname: ZHANG, ZHI-WEI
– fullname: LIU, YA-FEI
– fullname: ZHANG, ZHEN-HONG
– fullname: JIANG, MIN
– fullname: LIU, HAI-XIA
– fullname: HAN, XINGUN
– fullname: ZHU, JIAN-SHENG
– fullname: KOU, BU-YU
– fullname: CHEN, JIAN-GUO
– fullname: CHEN, SHUAI
– fullname: SHEN, HONG
BookMark eNqNyj0KAjEQBtAUWvh3h_EAgiRb2FiIKNovWC5D9ls2kGSWZLbQ09t4AKvXvLVZZMlYmfMzhZ4_EkGJfRH_9hGVBimkI0gLWBOykgzEs0pIac6gPlRwxdYsB44Vu58bs7_f2uvjgEk61Ik9MrRrX_ZoXWObk7u4f84XXksydA
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID TW202342483A
GroupedDBID EVB
ID FETCH-epo_espacenet_TW202342483A3
IEDL.DBID EVB
IngestDate Fri Oct 11 05:29:42 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language Chinese
English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_TW202342483A3
Notes Application Number: TW202312103466
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20231101&DB=EPODOC&CC=TW&NR=202342483A
ParticipantIDs epo_espacenet_TW202342483A
PublicationCentury 2000
PublicationDate 20231101
PublicationDateYYYYMMDD 2023-11-01
PublicationDate_xml – month: 11
  year: 2023
  text: 20231101
  day: 01
PublicationDecade 2020
PublicationYear 2023
RelatedCompanies F. HOFFMANN-LA ROCHE AG
RelatedCompanies_xml – name: F. HOFFMANN-LA ROCHE AG
Score 3.6373334
Snippet The present invention relates to compounds of formula (Ia), wherein R2, M1, M2, M3, Q1 and Q2 are as described herein, and their pharmaceutically acceptable...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title Imidazole macrocycles for the treatment of autoimmune disease
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20231101&DB=EPODOC&locale=&CC=TW&NR=202342483A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSUs2NjQ2TDbXTTExMNY1MUs10bVMSQb2UoA9FqOUROM0gyTQfmdfPzOPUBOvCNMIJoYs2F4Y8Dmh5eDDEYE5KhmY30vA5XUBYhDLBby2slg_KRMolG_vFmLrogbtHQMbK8AkpubiZOsa4O_i76zm7GwbEq7mFwSWMzEysTB2ZGZgBTWjQefsu4Y5gXalFCBXKW6CDGwBQNPySoQYmKoyhBk4nWE3rwkzcPhCJ7yBTGjeKxZhAPb_M1MSq_JzUhVyE4HFZ3IlaEGbArDRqQBsxCnAV4wr5KcpJJaW5GeCdn6kKkBnYEQZFN1cQ5w9dIHuiId7Oj4kHOFkYzEGlrz8vFQJBgXQ8V7GiZagbkkSsC5OBhZPSanA2ifV2DwZNGkmySCF2xwpfJLSDFwgDmSfnQwDS0lRaaossMItSZIDhxQAQzyFJA
link.rule.ids 230,309,786,891,25594,76904
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT4NAEJ7Uaqw3rRqtrzUx3IhtF4s9EGN5BLXQxqDtjcCyRIxCY2mM_fXOIm296G3DJJNls_P4mPkGgIuY0RZtMVWOlCaVlQ5X5G7EEKUgYmlHAY2boeA7O27HflLux1fjCrwuuDDFnNDPYjgiWhRDe88Lfz1ZfcQyit7K6WWY4KPsxvI0QyrRMSYreMUko6eZw4Ex0CVd17yR5D4WMqWtXNPbNVhXERKKOfvmc0-wUia_Q4q1DRtD1JbmO1CZv9Shpi_-vFaHTacseOOytL3pLiD-T6Jgnr1x8h6g-2RfoqGNYNJJMIkjy45xksUkmOVZIpgfnJQVmD04t0xPt2Xch798ad8brbZM96GaZik_ACLGe9GgK2BJiLGYoXsKOUYfTlUmimaH0PhbT-M_4RnUbM_p-_079-EItoTgh3N3DNX8Y8ZPMPjm4Wlxat-jp4gP
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Imidazole+macrocycles+for+the+treatment+of+autoimmune+disease&rft.inventor=GUBA%2C+WOLFGANG&rft.inventor=LIN%2C+ZHAO-HU&rft.inventor=WU%2C+YAO&rft.inventor=ZHU%2C+WEI&rft.inventor=ZHANG%2C+WEI-XING&rft.inventor=ZHANG%2C+ZHI-WEI&rft.inventor=LIU%2C+YA-FEI&rft.inventor=ZHANG%2C+ZHEN-HONG&rft.inventor=JIANG%2C+MIN&rft.inventor=LIU%2C+HAI-XIA&rft.inventor=HAN%2C+XINGUN&rft.inventor=ZHU%2C+JIAN-SHENG&rft.inventor=KOU%2C+BU-YU&rft.inventor=CHEN%2C+JIAN-GUO&rft.inventor=CHEN%2C+SHUAI&rft.inventor=SHEN%2C+HONG&rft.date=2023-11-01&rft.externalDBID=A&rft.externalDocID=TW202342483A